Otsuka And Abdi Ibrahim To Form Local Partnership

BMI View: Japanese global pharmaceutical firm Otsuka's partnership with Turkish drugmaker Abdi Ibrahim is another example of a multinational investing in one of Europe's larger emerging markets. Providing Otsuka is aware of the challenges in the Turkish drug market and has developed a strategy to minimise the downsides, the partnership should be favourable for both firms. The leading domestic player, Abdi Ibrahim will benefit from a wider range of innovative drugs that it can sell locally and to its' increasingly export-orientated market abroad.

To read the full article, please choose one of the following options: